Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Scott F. Harvey, President and CEO of Jones Soda Co. (NASDAQ: JSDA), executed a private placement transaction on July 7, 2026, acquiring 303,030 shares of common stock and 151,515 common stock warrants for a total of $99,999.90. The acquisition occurs as Jones Soda reports a significant financial turnaround in the first quarter of 2026, with revenu…
Energy Fuels Inc. (NYSE American: UUUU) director Bruce D. Hansen executed a purchase of 4,000 common shares on July 8, 2026, bringing his direct ownership to 313,844 shares. This transaction occurs as the company manages significant operational shifts, including a major acquisition, executive succession, and a conditional loan commitment from the U…
Helen Torley, President and CEO of Halozyme Therapeutics, Inc. (NASDAQ: HALO), executed a transaction involving the sale of 1,923 shares of the company's common stock on July 8, 2026. This activity followed the exercise of stock options to acquire an equivalent number of shares. The transactions were conducted under a pre-arranged trading plan esta…
Lightspeed Management Company, L.L.C., a significant ten percent stakeholder in Navan, Inc. (NASDAQ:NAVN), executed a sale of 8,983 Class A Common Stock shares on July 8, 2026, totaling $227,808. This transaction occurred at prices between $25.27 and $25.53, with a weighted average of $25.36 per share, shortly before Navan's stock closed at $25.63.…
Axon Enterprise Inc. CEO Patrick W. Smith completed a $6.4 million stock sale on July 7, 2026, under a Rule 10b5-1 trading plan established in May 2025. The transaction involved 9,817 shares sold between $626.78 and $662.695 per share, leaving Smith with 3,040,997 directly held shares. Despite the stock trading at $582, down 25.6% year-over-year, A…
Thomas C. Indelicarto, serving as Executive Vice President, General Counsel, and Secretary at Verisign Inc. (NASDAQ:VRSN), executed a sale of company equity on July 8, 2026. This transaction involved the disposal of 250 shares of Verisign common stock at a price point of $269.23 per share, resulting in total proceeds of $67,307. Post-transaction, I…
Lightspeed Management Company, L.L.C., a subsidiary within the Lightspeed Venture Partners network, has completely divested its entire position in Navan, Inc. (NASDAQ: NAVN). The firm executed the full exit on July 8, 2026, by selling 8,983 shares of Navan Class A Common Stock. The liquidation follows a complex series of internal, pro-rata, in-kind…
Maria Barak, Sunrun’s Chief Accounting Officer, completed a sale of 3,278 shares on July 9, 2026, valued at $39,893, executed under a pre-arranged trading plan. The transaction reduces her direct holdings to 90,033 shares, including restricted units subject to forfeiture. This financial activity occurs against a backdrop of stock volatility and con…
Douglas G. Beck, serving as Senior Vice President, General Counsel, Corporate Secretary, and Head of Investor and Shareholder Services at Covista Inc., recently executed a series of stock sales totaling $688,909. The transactions, which took place over two consecutive days in early July 2026, were conducted in accordance with a Rule 10b5-1 trading …
Robert J. Phelan, Chief Financial Officer of Covista Inc. (NASDAQ: CVSA), executed two separate sales of company common stock on July 7 and July 8, 2026, totaling $719,499. The transactions, conducted under a Rule 10b5-1 trading plan established in December 2025, reduced his direct holdings to 50,492 shares. The sales occurred while Covista is acti…
SailPoint, Inc. (NASDAQ:SAIL) Chief Financial Officer Brian Carolan has reduced his equity position in the identity security firm through a series of mandatory transactions. The sales, executed under a pre-established Rule 10b5-1 trading plan, were driven by tax withholding obligations related to the vesting of restricted stock units rather than di…
SailPoint Technologies Holdings (SAIL) Chief Executive Officer Mark D. McClain executed a series of mandatory stock sales totaling $3,362,812 across July 7 and July 8, 2026. The transactions, involving 211,454 shares, were processed under a Rule 10b5-1 trading plan to satisfy tax withholding requirements associated with the vesting of restricted st…
Michael A. Metzger, the Chief Executive Officer and a board member of Syndax Pharmaceuticals Inc (NASDAQ:SNDX), executed a sale of 32,375 shares of common stock on July 8, 2026. The transaction, valued at $784,776, was conducted through a Rule 10b5-1 trading plan. This sale occurs as the stock approaches its 52-week high of $25.59, following a subs…
Andres Ruiz Briseno, serving as the Chief Accounting Officer for IDEAYA Biosciences, Inc. (NASDAQ: IDYA), has executed a sale of 9,550 shares of the company's common stock. The transaction, valued at approximately $382,130, was conducted on July 7, 2026, under the parameters of a Rule 10b5-1 trading plan established in late 2025. This financial act…
SailPoint Technologies Holdings, Inc. (NASDAQ:SAIL) President Matt Mills executed a series of stock sales totaling approximately $1,237,227 over July 7 and July 8, 2026. The transactions, conducted under a Rule 10b5-1 trading plan to satisfy tax withholding obligations related to vesting restricted stock units, do not reflect discretionary trading …
Rezvan Mitra, the Chief Accounting Officer at SailPoint Technologies Holdings, Inc. (NASDAQ:SAIL), recently executed a series of stock sales totaling approximately $107,942. These transactions, conducted on July 7 and July 8, 2026, were not discretionary but rather mandatory sell-to-cover provisions tied to the vesting of restricted stock units. Th…
Jason Green, Executive Vice President and Chief Commercial Officer at Semtech Corp (NASDAQ:SMTC), executed a sale of company equity under a pre-established trading framework. The transaction occurs against a backdrop of analyst revisions and divergent internal valuation assessments. Market participants are monitoring the intersection of executive a…
Jamie L. Reynoso, Chief Executive Officer of Medicare Advantage at Clover Health Investments Corp., executed a share sale totaling $11,157 on July 8, 2026. The transaction involved the disposal of 2,384 shares of Class A Common Stock at $4.68 per share and was conducted under a Rule 10b5-1 trading plan established on March 12, 2026. Post-transactio…
Gnanasambandam Chandrasekar, Executive Vice President of Product and Chief Technology Officer at SailPoint, Inc. (NASDAQ:SAIL), has divested a portion of his equity holdings, selling $543,551 worth of common stock across two consecutive days in early July. The transactions, totaling 34,418 shares, were executed under a Rule 10b5-1 trading plan and …
Abby Payne, SailPoint's Chief People Officer, executed a series of stock sales totaling $612,928 in early July 2026. The transactions were conducted under a Rule 10b5-1 trading plan to satisfy mandatory tax withholding obligations from vesting restricted stock units. This structured divestment provides insight into executive compensation mechanics …
Sionna Therapeutics director Peter A. Thompson has executed a sale of approximately $3.85 million worth of company shares, according to a recent SEC Form 4 filing. The transaction, which took place on July 7, 2026, involved the disposal of 85,918 shares at $44.86 per share. This sale was conducted under a Rule 10b5-1 trading plan, a mechanism that …
Fordyce Marshall, President and CEO of Vera Therapeutics, Inc. (NASDAQ:VERA), executed a series of stock sales totaling approximately $1.96 million on July 7, 2026. The transactions involved 46,250 shares of Class A Common Stock, with prices ranging from $40.39 to $43.97 per share. These sales were carried out under a pre-arranged Rule 10b5-1 tradi…
OrbiMed Advisors LLC and OrbiMed Capital GP VIII LLC, both holding director positions at Sionna Therapeutics, Inc. (SION), executed a sale of approximately $3.85 million in common stock. The transaction, finalized on July 7, 2026, involved the disposal of 85,918 shares at $44.86 per share under a pre-arranged 10b5-1 trading plan. This sale occurs a…
Konstantin Lomashuk, a ten percent owner of FORUM MARKETS Inc (NASDAQ:FRMM), executed a series of stock sales totaling $30,476 in early July 2026. The transactions, facilitated through a Cayman Islands entity, reduce his indirect holdings while the company reports a significant net loss and initiates strategic reviews to bridge the gap between mark…
Christopher Schmitt, General Counsel and Secretary at SailPoint, Inc. (NYSE:SAIL), executed a series of stock sales totaling $681,137 on July 7 and July 8, 2026. The transactions, conducted under a Rule 10b5-1 trading plan, were non-discretionary and driven by mandatory sell-to-cover provisions for tax withholding obligations related to the vesting…
